Alternative GLP-1 compounds like retatrutide represent the next generation of multi-agonist compounds, targeting GLP-1, GIP, and glucagon receptors simultaneously
Integration with a broader metabolic plan Nutrition and lifestyle strategies to support insulin sensitivity, gut health, sleep, and stress
It uses the same molecule at a lower dose
The study in mice also found that treatment with Deltaran significantly decreased total spontaneous tumor incidence (by 2.6-fold), mainly mammary carcinomas and leukemias as compared with the control group
This normally enhances insulin release from the beta cells while suppressing glucagon release from the alpha cells, which also lie in the pancreas
That study was negative, although it suggested in the patients with the highest body weights that they did drink less when they were given the GLP-1 agonist